SLI
2.077,26
PKT
+5,99
PKT
+0,29
%
Werbung
Analysen zu SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
09.01.20 | Roche buy | Deutsche Bank AG | |
09.01.20 | Novartis Hold | Deutsche Bank AG | |
08.01.20 | Holcim overweight | Morgan Stanley | |
08.01.20 | UBS neutral | RBC Capital Markets | |
08.01.20 | UBS Sector Perform | RBC Capital Markets | |
08.01.20 | Nestlé Hold | HSBC | |
08.01.20 | Givaudan Sell | Goldman Sachs Group Inc. | |
07.01.20 | Swiss Re overweight | JP Morgan Chase & Co. | |
07.01.20 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
07.01.20 | Roche overweight | JP Morgan Chase & Co. | |
06.01.20 | Nestlé overweight | Barclays Capital | |
06.01.20 | UBS overweight | JP Morgan Chase & Co. | |
06.01.20 | Givaudan Underweight | Morgan Stanley | |
06.01.20 | Novartis verkaufen | Morgan Stanley | |
06.01.20 | Roche overweight | Morgan Stanley | |
06.01.20 | Novartis Underweight | JP Morgan Chase & Co. | |
06.01.20 | Roche overweight | JP Morgan Chase & Co. | |
06.01.20 | Zurich Insurance Hold | Deutsche Bank AG | |
06.01.20 | Swiss Re Hold | Deutsche Bank AG | |
02.01.20 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
02.01.20 | Roche overweight | JP Morgan Chase & Co. | |
20.12.19 | Nestlé buy | Jefferies & Company Inc. | |
17.12.19 | UBS buy | Kepler Cheuvreux | |
17.12.19 | Givaudan buy | UBS AG | |
17.12.19 | Novartis buy | Jefferies & Company Inc. | |
17.12.19 | Roche buy | Jefferies & Company Inc. | |
17.12.19 | ams-OSRAM Underweight | Barclays Capital | |
16.12.19 | Novartis Conviction Buy List | Goldman Sachs Group Inc. | |
16.12.19 | ams-OSRAM buy | Deutsche Bank AG | |
16.12.19 | Novartis Underweight | JP Morgan Chase & Co. | |
16.12.19 | Holcim overweight | Barclays Capital | |
13.12.19 | ams-OSRAM buy | Deutsche Bank AG | |
13.12.19 | Givaudan Neutral | JP Morgan Chase & Co. | |
13.12.19 | Nestlé overweight | JP Morgan Chase & Co. | |
12.12.19 | UBS Sector Perform | RBC Capital Markets | |
12.12.19 | Nestlé overweight | JP Morgan Chase & Co. | |
12.12.19 | Nestlé buy | Goldman Sachs Group Inc. | |
12.12.19 | Nestlé overweight | Barclays Capital | |
12.12.19 | Nestlé overweight | Morgan Stanley | |
12.12.19 | Roche buy | Deutsche Bank AG |